Ryan Reed wins at Chicagoland Speedway
JOLIET, Ill. (June 20, 2015) – Ryan Reed took the checkered flag on Saturday evening at Chicagoland Speedway in the ARCA Racing Series presented by Menards Scott 150 to capture his first career ARCA Series win and the first win for Lira Motorsports.
“I can’t thank Lira Motorsports enough for the opportunity to drive this car at Chicagoland,” said Reed. “Teddy Brown and the entire No. 58 Lilly Diabetes Lira Motorsports team put together a super-fast car and did a phenomenal job
of repairing it after the wreck in qualifying. I’m pumped to get my first ARCA win and get Lira Motorsports their first win as well.”
Reed, who races full-time for Roush Fenway Racing in the NASCAR Xfinity Series, is also the 15th different winner in 15 ARCA races at Chicagoland Speedway.
Reed started the 100-lap event from the 28th position after an incident in qualifying left major damage to the rear of the car, preventing him from completing a qualifying lap. The Lira Motorsports team repaired the damage to have the car race-ready just hours after the incident.
After taking the green flag on the 1.5-mile track, Reed quickly made his way through the field and into the fourth position by the Lap 12 caution flag.
Reed quickly reported that the car was handling really well and thanked the team for the repairs they had made after qualifying.
The 21-year-old Bakersfield, Calif. native made his way up to the second position by the Lap 23 caution flag and took the lead on Lap 31.
Crew chief Teddy Brown brought Reed down pit road for the team’s only pit stop of the day under caution on Lap 65. Reed’s Roush Fenway Racing XFINITY Series pit crew gave him four fresh tires and a full tank of fuel to complete the race at the head of the field.
Reed’s victory is his first in 15 starts in the ARCA Racing Series. His previous 14 starts came in 2012, with a best finish of fifth at Chicagoland. This was his first race in the driver’s seat for Lira Motorsports.
About Lilly Diabetes
Lilly has been a global leader in diabetes care since 1923, when we introduced the world’s first commercial insulin. Today we are building upon this heritage by working to meet the diverse needs of people with diabetes and those who care for them. Through research and collaboration, a broad and growing product portfolio and a continued determination to provide real solutions—from medicines to support programs and more—we strive to make life better for all those affected by diabetes around the world. For more information, visit www.lillydiabetes.com or follow us on Twitter: @LillyDiabetes.